Loading…
AXTA · NYSE · Specialty Chemicals
Specialty Chemicals company based in Philadelphia, Pennsylvania.
In the last 90 days, no insider of Axalta reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$32.68
Last 12 months
Not enough history
Market value
$6.99B
Revenue
$1.25B
−0.6% vs the same quarter a year earlier
Free cash flow, last 12 months
$488M
This quarter $18M, a year earlier −$17M
Net debt
$2.54B
Debt $3.15B, cash $608M, at Mar 31, 2026
Net income, last 12 months
$369M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 28, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$5.12B
−3.0% vs the year before
Net income, fiscal 2025
$378M
As reported in the annual filing
Shares outstanding
214M
As of Apr 23, 2026
In fiscal 2025 the company spent $165M buying back its own shares. Cash actually paid, from its cash-flow statement.
Nothing reported yet
New filings show up here as soon as they are processed.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
No disclosed open-market insider trades or Congressional trades in this period.
Adjusted close went from $28.18 on Oct 6, 2025 to $32.68 on Oct 5, 2026 (+16.0%). Disclosed activity in the last 12 months: 0 insider purchases, 0 insider sales, 0 Congress purchases, 0 Congress sales.